NT5E and head and neck squamous cell carcinoma: Expression of AR and the ectonucleosidases in cancers has been described for both CD73 (e.g., CRC, prostate, breast, HNSCC, ovarian, and melanoma) and CD39 (e.g., melanoma, ovarian, head, and neck cancer) [127].